Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:UROV

Urovant Sciences (UROV) Stock Price, News & Analysis

Urovant Sciences logo

About Urovant Sciences Stock (NASDAQ:UROV)

Advanced Chart

Key Stats

Today's Range
$16.24
$16.24
50-Day Range
$16.19
$16.24
52-Week Range
$7.15
$16.26
Volume
N/A
Average Volume
114,469 shs
Market Capitalization
$531.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive UROV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Urovant Sciences and its competitors with MarketBeat's FREE daily newsletter.

UROV Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

UROV Stock Analysis - Frequently Asked Questions

Urovant Sciences Ltd. (NASDAQ:UROV) released its quarterly earnings data on Thursday, February, 11th. The company reported ($1.46) EPS for the quarter, beating the consensus estimate of ($1.59) by $0.13.

Urovant Sciences (UROV) raised $150 million in an IPO on Thursday, September 27th 2018. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, Jefferies and Cowen acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Urovant Sciences investors own include Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), Xeris Biopharma (XERS), Akero Therapeutics (AKRO), Aldeyra Therapeutics (ALDX), Idera Pharmaceuticals (IDRA) and Kaleido Biosciences (KLDO).

Company Calendar

Last Earnings
2/11/2021
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:UROV
CIK
1740547
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.71)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$146.74 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-162.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.91
Quick Ratio
2.91

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.90) per share
Price / Book
-8.55

Miscellaneous

Outstanding Shares
32,743,000
Free Float
N/A
Market Cap
$531.75 million
Optionable
Not Optionable
Beta
2.36
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:UROV) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners